• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在STOP研究中,经颅多普勒超声筛查儿童的中风及转化为高风险情况。

Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study.

作者信息

Adams Robert J, Brambilla Donald J, Granger Suzanne, Gallagher Dianne, Vichinsky Elliott, Abboud Miguel R, Pegelow Charles H, Woods Gerald, Rohde Elizabeth M, Nichols Fenwick T, Jones Anne, Luden Judith P, Bowman Latonya, Hagner Susan, Morales Knashawn H, Roach E Steve

机构信息

Department of Neurology, Medical College of Georgia, Augusta, GA 30912-3200, USA.

出版信息

Blood. 2004 May 15;103(10):3689-94. doi: 10.1182/blood-2003-08-2733. Epub 2004 Jan 29.

DOI:10.1182/blood-2003-08-2733
PMID:14751925
Abstract

The Stroke Prevention Trial in Sickle Cell Anemia (STOP) was a randomized multicenter controlled trial comparing prophylactic blood transfusion with standard care in sickle cell anemia (SCA) children aged 2 to 16 years selected for high stroke risk by transcranial Doppler (TCD). More than 2000 children were screened with TCD to identify the 130 high-risk children who entered the randomized trial. A total of 5613 TCD studies from 2324 children were evaluated. We also collected information on stroke. We describe the changes in TCD with repeated testing and report the outcome without transfusion in the STOP screened cohort. Risk of stroke was higher with abnormal TCD than with normal or conditional TCD (P <.001) or inadequate TCD (P =.002), and risk with conditional TCD was higher than with normal TCD (P <.001). Repeated TCD in 1215 children showed that the condition of 9.4% of children became abnormal during observation. Younger patients and those with higher initial flow velocities were most likely to convert to abnormal TCDs. Screening in STOP confirmed the predictive value of TCD for stroke. Substantial differences in the probability of conversion to abnormal TCD were observed, with younger children and those with higher velocity more likely to have an abnormal TCD with rescreening.

摘要

镰状细胞贫血症预防中风试验(STOP)是一项随机多中心对照试验,比较了预防性输血与标准治疗方案对年龄在2至16岁、经经颅多普勒(TCD)检查确定为中风高危的镰状细胞贫血症(SCA)儿童的疗效。超过2000名儿童接受了TCD筛查,以确定130名进入随机试验的高危儿童。共评估了来自2324名儿童的5613次TCD检查。我们还收集了中风相关信息。我们描述了重复检查时TCD的变化,并报告了STOP筛查队列中未接受输血的结果。TCD异常者的中风风险高于TCD正常或条件性正常者(P<.001)或TCD检查不充分者(P =.002),条件性正常TCD者的中风风险高于正常TCD者(P<.001)。对1215名儿童进行的重复TCD检查显示,9.4%的儿童在观察期间TCD状况变为异常。年龄较小的患者和初始血流速度较高的患者最有可能转变为TCD异常。STOP试验中的筛查证实了TCD对中风的预测价值。观察到转变为TCD异常的概率存在显著差异,年龄较小及血流速度较高的儿童再次筛查时更有可能出现TCD异常。

相似文献

1
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study.在STOP研究中,经颅多普勒超声筛查儿童的中风及转化为高风险情况。
Blood. 2004 May 15;103(10):3689-94. doi: 10.1182/blood-2003-08-2733. Epub 2004 Jan 29.
2
Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?收缩期峰值速度能否用于预测镰状细胞贫血患者的中风?
Pediatr Radiol. 2005 Jan;35(1):66-72. doi: 10.1007/s00247-004-1282-9. Epub 2004 Oct 23.
3
Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.接受慢性输血以预防首发卒中的镰状细胞贫血儿童的经颅多普勒速度和脑 MRI/MRA 变化。
Pediatr Blood Cancer. 2013 Sep;60(9):1499-502. doi: 10.1002/pbc.24569. Epub 2013 Apr 26.
4
Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia.镰状细胞贫血患儿经颅彩色多普勒成像(TCDI)与经颅多普勒(TCD)的比较。
Pediatr Radiol. 2001 Jul;31(7):461-9. doi: 10.1007/s002470100427.
5
Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease.输血疗法对镰状细胞病患儿经颅多普勒超声速度的影响。
Pediatr Blood Cancer. 2011 May;56(5):777-82. doi: 10.1002/pbc.22951. Epub 2010 Dec 23.
6
Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation.经颅多普勒(TCD)筛查在镰状细胞贫血预防中风中的应用:技术差异的陷阱
Pediatr Radiol. 2000 Nov;30(11):733-8. doi: 10.1007/s002470000317.
7
Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia.镰状细胞贫血患儿全面经颅多普勒筛查项目的评估
Pediatr Blood Cancer. 2008 Apr;50(4):818-21. doi: 10.1002/pbc.21430.
8
Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing.镰状细胞病卒中预防(STOP)研究经颅多普勒检测指南
J Neuroimaging. 2001 Oct;11(4):354-62. doi: 10.1111/j.1552-6569.2001.tb00063.x.
9
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.镰状细胞贫血症中风预防试验(STOP):延长随访及最终结果
Blood. 2006 Aug 1;108(3):847-52. doi: 10.1182/blood-2005-10-009506.
10
Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.在尼日利亚队列中,羟基脲可降低镰状细胞贫血患儿的经颅多普勒血流速度。
Pediatr Blood Cancer. 2015 Sep;62(9):1587-91. doi: 10.1002/pbc.25529. Epub 2015 Apr 1.

引用本文的文献

1
Identifying research activity on brain ultrasonography in craniocerebral diseases by bibliometric and visualized analysis of a 20-year journey of global publications.通过对20年全球出版物历程的文献计量学和可视化分析,确定颅脑疾病中脑超声检查的研究活动。
Medicine (Baltimore). 2025 Mar 21;104(12):e41927. doi: 10.1097/MD.0000000000041927.
2
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial.西班牙裔镰状细胞贫血儿童的中风预防:SACRED试验
Blood Adv. 2025 Apr 22;9(8):1791-1800. doi: 10.1182/bloodadvances.2024014327.
3
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.
乌干达儿童镰状细胞贫血神经和认知保护的羟基脲治疗(BRAIN SAFE II):单臂开放标签试验方案
Contemp Clin Trials Commun. 2024 Nov 28;42:101404. doi: 10.1016/j.conctc.2024.101404. eCollection 2024 Dec.
4
Longitudinal outcomes of chronically transfused adults with sickle cell disease and a history of childhood stroke.患有镰状细胞病且有儿童期卒中病史的长期接受输血的成年人的纵向转归。
Transfusion. 2024 Dec;64(12):2260-2269. doi: 10.1111/trf.18041. Epub 2024 Nov 5.
5
Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.乌干达儿童镰状细胞贫血神经和认知保护的羟基脲疗法(BRAIN SAFE II):单臂开放标签试验方案
medRxiv. 2024 Jan 13:2024.01.12.24301208. doi: 10.1101/2024.01.12.24301208.
6
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens.在低收入非洲环境下使用羟基脲治疗镰状细胞贫血的成本效益:两种剂量方案的基于模型评估。
Pharmacoeconomics. 2023 Dec;41(12):1603-1615. doi: 10.1007/s40273-023-01294-3. Epub 2023 Jul 18.
7
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.羟基脲加量用于坦桑尼亚镰状细胞贫血儿童一级卒中预防(SPHERE):一项开放标签、2 期试验。
Lancet Haematol. 2023 Apr;10(4):e261-e271. doi: 10.1016/S2352-3026(22)00405-7. Epub 2023 Mar 1.
8
Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.全基因组关联研究发现,巴西镰状细胞病患者的早期缺血性卒中风险与 ADAMTS2 和 CDK18 相关,并揭示了新的发病部位。
Br J Haematol. 2023 Apr;201(2):343-352. doi: 10.1111/bjh.18637. Epub 2023 Jan 5.
9
Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study.法属圭亚那镰状细胞病患儿中风风险低:一项回顾性队列研究。
Front Med (Lausanne). 2022 Jun 28;9:851918. doi: 10.3389/fmed.2022.851918. eCollection 2022.
10
Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis.预防性羟基脲治疗与镰状细胞病患者脑血流动力学改善相关,脑血流动力学改善是卒中风险的替代标志物:一项回顾性比较分析。
J Clin Med. 2022 Jun 17;11(12):3491. doi: 10.3390/jcm11123491.